361 related articles for article (PubMed ID: 29678529)
21. Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial.
Kitz J; Fokas E; Beissbarth T; Ströbel P; Wittekind C; Hartmann A; Rüschoff J; Papadopoulos T; Rösler E; Ortloff-Kittredge P; Kania U; Schlitt H; Link KH; Bechstein W; Raab HR; Staib L; Germer CT; Liersch T; Sauer R; Rödel C; Ghadimi M; Hohenberger W;
JAMA Surg; 2018 Aug; 153(8):e181607. PubMed ID: 29874375
[TBL] [Abstract][Full Text] [Related]
22. Tumour regression grading after chemoradiotherapy for locally advanced rectal cancer: a near pathologic complete response does not translate into good clinical outcome.
Swellengrebel HA; Bosch SL; Cats A; Vincent AD; Dewit LG; Verwaal VJ; Nagtegaal ID; Marijnen CA
Radiother Oncol; 2014 Jul; 112(1):44-51. PubMed ID: 25018000
[TBL] [Abstract][Full Text] [Related]
23. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
[TBL] [Abstract][Full Text] [Related]
24. Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer.
Tural D; Ozturk M; Selcukbiricik F; Yildiz O; Elicin O; Turna H; Guney S; Ozguroglu M
J BUON; 2013; 18(2):385-90. PubMed ID: 23818350
[TBL] [Abstract][Full Text] [Related]
25. Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial.
Rullier E; Vendrely V; Asselineau J; Rouanet P; Tuech JJ; Valverde A; de Chaisemartin C; Rivoire M; Trilling B; Jafari M; Portier G; Meunier B; Sieleznieff I; Bertrand M; Marchal F; Dubois A; Pocard M; Rullier A; Smith D; Frulio N; Frison E; Denost Q
Lancet Gastroenterol Hepatol; 2020 May; 5(5):465-474. PubMed ID: 32043980
[TBL] [Abstract][Full Text] [Related]
26. Role of Preoperative Chemoradiotherapy in Clinical Stage II/III Rectal Cancer Patients Undergoing Total Mesorectal Excision: A Retrospective Propensity Score Analysis.
Lee JB; Kim HS; Ham A; Chang JS; Shin SJ; Beom SH; Koom WS; Kim T; Han YD; Han DH; Hur H; Min BS; Lee KY; Kim NK; Park YR; Lim JS; Ahn JB
Front Oncol; 2020; 10():609313. PubMed ID: 33537238
[TBL] [Abstract][Full Text] [Related]
27. Oncologic outcome after preoperative chemoradiotherapy in patients with pathologic T0 (ypT0) rectal cancer.
Jang TY; Yu CS; Yoon YS; Lim SB; Hong SM; Kim TW; Kim JH; Kim JC
Dis Colon Rectum; 2012 Oct; 55(10):1024-31. PubMed ID: 22965400
[TBL] [Abstract][Full Text] [Related]
28. Total mesorectal excision with or without preoperative chemoradiotherapy for resectable mid/low rectal cancer: a long-term analysis of a prospective, single-center, randomized trial.
Wang F; Fan W; Peng J; Lu Z; Pan Z; Li L; Gao Y; Li H; Chen G; Wu X; Ding P; Zeng Z; Wan D
Cancer Commun (Lond); 2018 Dec; 38(1):73. PubMed ID: 30572939
[TBL] [Abstract][Full Text] [Related]
29. Outcomes and prognostic factors of selective lateral pelvic lymph node dissection with preoperative chemoradiotherapy for locally advanced rectal cancer.
Matsuda T; Sumi Y; Yamashita K; Hasegawa H; Yamamoto M; Matsuda Y; Kanaji S; Oshikiri T; Nakamura T; Suzuki S; Kakeji Y
Int J Colorectal Dis; 2018 Apr; 33(4):367-374. PubMed ID: 29442155
[TBL] [Abstract][Full Text] [Related]
30. Different Impacts of Preoperative Radiotherapy and Chemoradiotherapy on Oncological Outcomes in Patients with Stages II and III Lower Rectal Cancer: A Propensity Score Analysis.
Takiyama H; Kawai K; Ishihara S; Yasuda K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Hata K; Nozawa H; Morikawa T; Watanabe T
Dig Surg; 2018; 35(3):212-219. PubMed ID: 28637039
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of neoadjuvant chemoradiotherapy followed by total mesorectal excision surgery for locally advanced rectal cancer: a single-institution experience.
Tseng MSF; Zheng H; Ng IWS; Leong YH; Leong CN; Yong WP; Cheong WK; Tey JCS
Singapore Med J; 2018 Jun; 59(6):305-310. PubMed ID: 29167909
[TBL] [Abstract][Full Text] [Related]
32. Oncological Outcomes of Lateral Pelvic Lymph Node Metastasis in Rectal Cancer Treated With Preoperative Chemoradiotherapy.
Ishihara S; Kawai K; Tanaka T; Kiyomatsu T; Hata K; Nozawa H; Morikawa T; Watanabe T
Dis Colon Rectum; 2017 May; 60(5):469-476. PubMed ID: 28383446
[TBL] [Abstract][Full Text] [Related]
33. Factors that influence the adequacy of total mesorectal excision for rectal cancer.
Jeyarajah S; Sutton CD; Miller AS; Hemingway D;
Colorectal Dis; 2007 Nov; 9(9):808-15. PubMed ID: 17441969
[TBL] [Abstract][Full Text] [Related]
34. Comparison of treatment results between surgery alone, preoperative short-course radiotherapy, or long-course concurrent chemoradiotherapy in locally advanced rectal cancer.
Yeh CH; Chen MF; Lai CH; Huang WS; Lee SP; Chen WC
Int J Clin Oncol; 2012 Oct; 17(5):482-90. PubMed ID: 21938495
[TBL] [Abstract][Full Text] [Related]
35. Comparing neoadjuvant therapy followed by local excision to total mesorectal excision in the treatment of early stage rectal cancer: a systematic review and meta-analysis of randomised clinical trials.
Lynch P; Ryan OK; Donnelly M; Ryan ÉJ; Davey MG; Reynolds IS; Creavin B; Hanly A; Kennelly R; Martin ST; Winter DC
Int J Colorectal Dis; 2023 Nov; 38(1):263. PubMed ID: 37924372
[TBL] [Abstract][Full Text] [Related]
36. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis.
Renehan AG; Malcomson L; Emsley R; Gollins S; Maw A; Myint AS; Rooney PS; Susnerwala S; Blower A; Saunders MP; Wilson MS; Scott N; O'Dwyer ST
Lancet Oncol; 2016 Feb; 17(2):174-183. PubMed ID: 26705854
[TBL] [Abstract][Full Text] [Related]
37. Local excision of low rectal cancer treated by chemoradiotherapy: is it safe for all patients with suspicion of complete tumor response?
Debove C; Guedj N; Tribillon E; Maggiori L; Zappa M; Panis Y
Int J Colorectal Dis; 2016 Apr; 31(4):853-60. PubMed ID: 26951185
[TBL] [Abstract][Full Text] [Related]
38. Is it time to rethink the rule of total mesorectal excision? A prospective radiological and pathological study in 49 consecutive patients with mid-rectal cancer.
Guedj N; Zappa M; Maggiori L; Bertin C; Hennequin C; Panis Y
Colorectal Dis; 2016 Sep; 18(9):O314-21. PubMed ID: 27381492
[TBL] [Abstract][Full Text] [Related]
39. Postoperative Chemoradiotherapy After Local Resection for High-Risk T1 to T2 Low Rectal Cancer: Results of a Single-Arm, Multi-Institutional, Phase II Clinical Trial.
Sasaki T; Ito Y; Ohue M; Kanemitsu Y; Kobatake T; Ito M; Moriya Y; Saito N
Dis Colon Rectum; 2017 Sep; 60(9):914-921. PubMed ID: 28796729
[TBL] [Abstract][Full Text] [Related]
40. [Comparison of preoperative chemotherapy with concurrent chemoradiotherapy combined with TME for 305 patients with locally advanced rectal cancer].
Muyasha A; Liu WY; Jin J; Li S; Tang Y; Li N; Ren H; Fang H; Lu NN; Tang Y; Chen B; Wang SL; Song YW; Liu YP; Qi SN; Li YX
Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):1122-1131. PubMed ID: 34695905
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
